NCT06144931

Efficacy of Pericapsular Nerve Group (PENG) Block for Hip Surgeries

Name: Clinical Trial NCT06144931
Creator: Suez Canal University
Keywords: Pain, Postoperative, PENG Block, procedure, clinical trial, Egypt

The Impact of Pericapsular Nerve Group Block on The Duration of Post-Operative Analgesia Following Hip Joint Surgeries

Suez Canal University·ClinicalTrials.gov·procedureRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Pain, Postoperative
Drug/Device/Intervention: PENG Block
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: Suez Canal University
Location: Ismailia, Egypt

Timeline & enrollment

Phase: N/A
Start date: Jun 01, 2023
End date: Mar 01, 2024
Enrollment: 38 participants

Primary outcome

The time of first request of analgesia in both groups

Summary

To study the efficacy of the PENG block on the duration of postoperative analgesia. There are two groups of patients, who are undergoing hip joint surgeries, one group (Control Group) will receive spinal anesthesia only while the other group (PENG Group) will receive PENG block before spinal anesthesia.

ICD-10 classifications

During surgical operationDuring surgical operationDuring surgical operationPain, unspecifiedPostoperative intestinal obstruction

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06144931
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06144931 through Pure Global AI's free database. This phase not specified trial is sponsored by Suez Canal University and is currently Recruiting. The study focuses on Pain, Postoperative. Target enrollment is 38 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.